These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10148463)

  • 21. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alternative methods in interventional therapy of coronary heart disease].
    Erbel R; Ge J; Haude M; Görge G
    Z Kardiol; 1995; 84 Suppl 2():53-64. PubMed ID: 7571784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary stents in the management of coronary artery disease review of first 100 stents.
    Ng SC; Sawatt C; Foo LK; Hitam O; Khor PG; Lee YK
    Med J Malaysia; 1996 Mar; 51(1):75-9. PubMed ID: 10967983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. Heparin Registry Investigators.
    Ferguson JJ; Barasch E; Wilson JM; Strony J; Wolfe MW; Schweiger MJ; Leya F; Bonan R; Isner JM; Roubin GS
    J Invasive Cardiol; 1995; 7(1):2-10. PubMed ID: 10155653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelation between atherosclerosis and restenosis.
    Kranzhöfer R; Libby P
    Z Kardiol; 1995; 84 Suppl 4():125-8. PubMed ID: 8585264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concepts for local therapy of restenosis].
    Riessen R; Oberhoff M; Karsch KR
    Z Kardiol; 1996; 85 Suppl 1():87-98. PubMed ID: 8882829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of atherectomy for peripheral arterial occlusive disease.
    Ahn SS; Concepcion B
    World J Surg; 1996; 20(6):635-43. PubMed ID: 8662146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions.
    Moses JW; Moussa I; Popma JJ; Sketch MH; Yeh W
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):149-54. PubMed ID: 10376493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New developments in coronary stent technology.
    Smith EJ; Jain AK; Rothman MT
    J Interv Cardiol; 2006 Dec; 19(6):493-9. PubMed ID: 17107363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Morphologic studies following coronary thrombolysis and PTCA].
    Hort W; Vogelsang H
    Z Kardiol; 1986; 75 Suppl 5():65-71. PubMed ID: 2950674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update in management of coronary bifurcation lesions in the drug-eluting stent era.
    Sharma SK
    Indian Heart J; 2006; 58(2):108-19. PubMed ID: 18989054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary laser angioplasty.
    Deckelbaum LI
    Lasers Surg Med; 1994; 14(2):101-10. PubMed ID: 8183044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vulnerable plaque: definition, diagnosis, and treatment.
    Moreno PR
    Cardiol Clin; 2010 Feb; 28(1):1-30. PubMed ID: 19962047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond stents: third-generation coronary devices.
    Oesterle SN
    Ann Thorac Surg; 1998 Sep; 66(3):1045-9. PubMed ID: 9769000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
    Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
    J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.